Pharma stocks: regarding China Trump softness of Too in the market heat could not fill Is. Nifty around 100 point With a fall below 25200 Doing business. Although good in banking stocks recovery Is. midcap And small cap Today support the market not giving, Fear Index (Volatility index) INDIA VIX 10 percent jumped more than Is. nifty pharma There is a weakness of 0.42 percent in the index and it is seen around 22,124.60. This segment In Divis Lab And Cipla Come focus In
Divis Lab It is trading around Rs 6,609 with a gain of 134.50 points or 2.08 percent. There itself, Cipla in 0.41 percent of weakness Of with business yes remained Is,
cnbc-of voice managing editor younger brother Singhal choice of
younger brother Singhal insist that nifty Pharma and nifty weekly ratio chart see So Clean Would Is That Nifty against Nifty Pharma Of outperform signs to do Are meeting. nifty Pharma Of close to two and a half of the year trendline support From outperform to do signs of Are meeting. relative strength on the scale of Pharma Share stronger than Nifty Are visible.
Divis Lab WEEKLY visible on chart Strong
younger brother Singhal said that Divis Lab WEEKLY in chart same one candle in 20 WEMA and 50 WMA across It is done. more than 4 times on Monday delivery volume Has been seen. delivery volume at the peak of a quarter It is visible. of three days Short covering fantastic after Long build up has been seen
CIPLA Too WEEKLY on the chart Strong It is visible. In this 100 WMA support shopping at Has been seen. its tomorrow 20 and 50 WMA over the closing Has happened. better than two days delivery shopping Is being seen. strong in futures Long build-up Has been seen.
If we look at the movement of these shares Cipla 4.00 rupees i.e. 0.26 It is trading around Rs 1558 with a weakness of per cent. Today its daily low is Rs 1,550.10 and daily high is Rs 1,563.10. There itself, divis laboratory It is seen around Rs 6580 with an increase of Rs 105.50 i.e. 1.63 percent. Today its daily high is Rs 6,620 and daily low is Rs 6,439.50.
Disclaimer, moneycontrol.com views given on expert Has his own personal views. website or management for this Responsible Not there. users To money control It is advised that before taking any investment decision certified expert Take advice.